12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

12/2024

Dec 20, 2024, 22:59 | Insight
ALTHEA: Transforming Mental Health Support in Cancer Care Through Innovation
European Cancer Organisation (ECO) shared a post on LinkedIn: “Cancer doesn’t only affect the body;…
Dec 20, 2024, 22:56 | Insight
Tracey O’Brien: Excited to share this year’s cancer in NSW 2024 report
Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, shared a…
Dec 20, 2024, 22:49 | Science
High-risk defining events in follicular lymphoma following front line immunochemotherapy
Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of…
Dec 20, 2024, 22:35 | Blog
Jennifer S. Buell: Transforming cancer care through innovation in immuno-oncology
Jennifer S. Buell, President and Chief Executive Officer at MiNK Therapeutics, posted the following on…
Dec 20, 2024, 21:30 | Science
Razelle Kurzrock: If it’s a solid tumor target, it may be a heme target
Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center,…
Dec 20, 2024, 21:15 | Blog
Cancer Discovery: Nominations for the Cancer Discovery Early Career Award
Cancer Discovery shared a post on X: "Reminder—nominations for the Cancer Discovery Early Career Award…
Dec 20, 2024, 18:43 | Insight
FDA Approves Remestemcel-L for Steroid-Refractory GvHD in Pediatric Patients
On December 18, 2024, FDA approved remestemcel-L-rknd (Ryoncil, Mesoblast, Inc.), an allogeneic bone marrow-derived mesenchymal…
Dec 20, 2024, 18:36 | Blog
Oracle Head and Neck Cancer UK Announced £300,000 Research Grant to Propel Innovation in Cancer Research and Patient Care
Oracle Head & Neck Cancer UK, in partnership with a family foundation, is excited to…
Dec 20, 2024, 18:34 | Blog
The SWOG/Hope Foundation Impact Award program
The SWOG/Hope Foundation Impact Award program is designed to support the early and conceptual stages…
Dec 20, 2024, 18:25 | Drugs
Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia
On 19th December, Nurix Therapeutics has announced that the U.S. Food and Drug Administration (FDA)…
All: 2613 Posts: 831 - 840
Special Coverage